News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Manufacturing
Deals
Business
Job Trends
Cell and Gene Therapy
Cancer
Opinions
Press Releases
All News & Releases
Podcasts
Events
Jobs
Companies
Hotbeds
More
Reports
Career Advice
NextGen: Top Startups to Watch
40 Under 40
Best Places to Work
Employer Resources
Advertise
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Submit an Event
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
276,350 Results
Type
Article (18121)
Company Profile (116)
Press Release (258109)
Multimedia
Podcasts (76)
Webinars (16)
Section
Business (72306)
Career Advice (1280)
Deals (12022)
Drug Delivery (74)
Drug Development (32255)
Employer Resources (157)
FDA (7200)
Job Trends (7183)
News (125183)
Policy (11153)
Tag
2027 Biotech Bay Standard (1)
2027 Genetown Elite (2)
2027 Genetown Standard (1)
2027 Pharm Country Elite (1)
2027 Pharm Country Standard (3)
Academia (1387)
Academic (1)
Accelerated approval (19)
Adcomms (4)
Allergies (112)
Alliances (20330)
ALS (100)
Alzheimer's disease (738)
Antibody-drug conjugate (ADC) (112)
Approvals (7441)
Artificial intelligence (281)
Autoimmune disease (87)
Automation (24)
Bankruptcy (79)
Best Places to Work (6085)
BIOSECURE Act (11)
Biosimilars (69)
Biotechnology (67)
Bladder cancer (82)
Brain cancer (27)
Breast cancer (305)
Cancer (2132)
Cardiovascular disease (197)
Career advice (1124)
Career pathing (32)
CAR-T (149)
CDC (17)
Celiac Disease (1)
Cell therapy (432)
Cervical cancer (18)
Clinical research (28887)
Collaboration (901)
Compensation (371)
Complete response letters (23)
COVID-19 (966)
CRISPR (96)
C-suite (480)
Cystic fibrosis (116)
Data (3407)
Decentralized trials (1)
Denatured (8)
Depression (75)
Diabetes (262)
Diagnostics (3015)
Digital health (21)
Diversity (7)
Diversity, equity & inclusion (38)
Drug discovery (129)
Drug pricing (80)
Drug shortages (11)
Duchenne muscular dystrophy (119)
Earnings (23460)
Editorial (61)
Employer branding (24)
Employer resources (135)
Events (43781)
Executive appointments (550)
FDA (8997)
Fibrodysplasia Ossificans Progressiva (5)
Friedreich's ataxia (6)
Frontotemporal dementia (7)
Funding (860)
Gene editing (211)
Generative AI (29)
Gene therapy (424)
GLP-1 (401)
Government (1836)
Grass and pollen (2)
Guidances (186)
Healthcare (8687)
HIV (28)
Huntington's disease (29)
IgA nephropathy (61)
Immunology and inflammation (94)
Immuno-oncology (19)
Indications (52)
Infectious disease (1070)
Inflammatory bowel disease (111)
Inflation Reduction Act (8)
Influenza (41)
Intellectual property (103)
Interviews (205)
IPO (5622)
IRA (24)
Job creations (1304)
Job search strategy (962)
JPM (31)
Kidney cancer (1)
Labor market (83)
Layoffs (175)
Leadership (24)
Legal (1799)
Liver cancer (46)
Longevity (11)
Lung cancer (256)
Lymphoma (177)
Machine learning (26)
Management (49)
Manufacturing (397)
MASH (71)
Medical device (5741)
Medtech (5765)
Mergers & acquisitions (6949)
Metabolic disorders (578)
Multiple sclerosis (70)
NASH (7)
Neurodegenerative disease (159)
Neuropsychiatric disorders (33)
Neuroscience (1406)
Neurotech (1)
NextGen: Class of 2026 (3171)
Non-profit (2935)
Now hiring (66)
Obesity (224)
Opinion (165)
Ovarian cancer (74)
Pain (94)
Pancreatic cancer (95)
Parkinson's disease (169)
Partnered (19)
Patents (166)
Patient recruitment (251)
Peanut (50)
People (25798)
Pharmaceutical (30)
Pharmacy benefit managers (11)
Phase 1 (8295)
Phase 2 (12492)
Phase 3 (10777)
Pipeline (2628)
Policy (127)
Postmarket research (1037)
Preclinical (3263)
Press Release (57)
Prostate cancer (124)
Psychedelics (19)
Radiopharmaceuticals (120)
Rare diseases (602)
Real estate (2683)
Recruiting (63)
Regulatory (9799)
Reports (48)
Research institute (1324)
Resumes & cover letters (183)
Rett syndrome (26)
RNA editing (13)
RSV (29)
Schizophrenia (81)
Series A (151)
Series B (109)
Service/supplier (5)
Sickle cell disease (85)
Special edition (26)
Spinal muscular atrophy (102)
Sponsored (33)
Startups (2005)
State (1)
Stomach cancer (4)
Supply chain (46)
Tariffs (19)
The Weekly (67)
Vaccines (327)
Venture capital (63)
Weight loss (141)
Women's health (40)
Worklife (20)
Date
Last 7 days (285)
Last 30 days (1043)
Last 365 days (14772)
2026 (1412)
2025 (15116)
2024 (17088)
2023 (18990)
2022 (23461)
2021 (26097)
2020 (23676)
2019 (21180)
2018 (15782)
2017 (13361)
2016 (12586)
2015 (14483)
2014 (10326)
2013 (7920)
2012 (8175)
2011 (8516)
2010 (7277)
Location
Africa (442)
Alabama (38)
Alaska (7)
Arizona (118)
Arkansas (7)
Asia (15707)
Australia (3022)
California (5359)
Canada (1383)
China (449)
Colorado (254)
Connecticut (255)
Delaware (193)
Europe (41790)
Florida (839)
Georgia (193)
Hawaii (3)
Idaho (19)
Illinois (393)
India (41)
Indiana (375)
Iowa (20)
Japan (331)
Kansas (47)
Kentucky (21)
Louisiana (15)
Maine (27)
Maryland (618)
Massachusetts (4252)
Michigan (130)
Minnesota (289)
Mississippi (5)
Missouri (58)
Montana (18)
Nebraska (7)
Nevada (66)
New Hampshire (20)
New Jersey (1577)
New Mexico (17)
New York (1484)
North Carolina (843)
North Dakota (8)
Northern California (2539)
Ohio (179)
Oklahoma (9)
Oregon (22)
Pennsylvania (1088)
Puerto Rico (14)
Rhode Island (20)
South America (561)
South Carolina (9)
South Dakota (1)
Southern California (2128)
Tennessee (58)
Texas (687)
United States (19572)
Utah (133)
Virginia (117)
Washington D.C. (48)
Washington State (384)
West Virginia (2)
Wisconsin (73)
Wyoming (1)
276,350 Results for "life edit therapeutics.rss".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Wave Life Sciences Highlights Strategic Priorities for 2026 at the 44th Annual J.P. Morgan Healthcare Conference: Accelerating Development of WVE-007 (INHBE siRNA) for Obesity and Rapidly Advancing RNA Editing Portfolio
January 12, 2026
·
12 min read
Gene editing
Regeneron Makes $275M Gene Editing Play With Tessera Partnership Targeting AATD
The centerpiece of the deal is the
in vivo
editor TSRA-196, which in preclinical studies has shown robust editing at SERPINA1, the locus linked to alpha-1 antitrypsin deficiency.
December 1, 2025
·
1 min read
·
Tristan Manalac
Gene editing
FDA Eyes Accelerated Reviews for Gene Editing Therapies
Vinay Prasad, chief of the FDA’s Center for Biologics Evaluation and Research, is planning to publish a paper this month to outline his office’s thinking on accelerating gene editing reviews.
November 3, 2025
·
2 min read
·
Tristan Manalac
Press Releases
REPROCELL Launches StemEdit - Clinical Gene Editing Services and New iPSC Lines Using AI-Designed editing tools
January 29, 2026
·
2 min read
Press Releases
Cellares to Expand Automated Manufacturing to Gene-Edited Stem Cell Therapies
February 4, 2026
·
3 min read
Press Releases
Alira Health Opens the Registration for the Third Edition of the Global Payer Forum
January 29, 2026
·
3 min read
Gene editing
FDA Lifts One of Two Clinical Holds on Intellia’s ATTR Gene Editing Program
After a patient safety signal and then death, the FDA in October 2025 placed holds on two of the company’s CRISPR programs for hereditary transthyretin amyloidosis.
January 27, 2026
·
2 min read
·
Dan Samorodnitsky
Press Releases
Aurora Therapeutics Launches to Realize Potential of Personalized Gene Editing for Millions of Patients with Rare Diseases
January 9, 2026
·
6 min read
Job Trends
BioSpace
Reveals Fresh Design With 2026 Hotbed Maps, Highlighting Life Sciences Hubs
BioSpace
has revealed its new 2026 Hotbed Maps, showcasing seven regional life sciences hot spots.
January 20, 2026
·
2 min read
·
Chantal Dresner
Gene editing
Lilly Leans Into Hearing Loss in $1.12B+ Gene Editing Pact With Seamless
The deal will help bolster Eli Lilly’s growing hearing loss portfolio, which is anchored by the gene therapy AK-OTOF.
January 28, 2026
·
2 min read
·
Tristan Manalac
1 of 27,635
Next
